0001948657-25-000003.txt : 20251031 0001948657-25-000003.hdr.sgml : 20251031 20251030182036 ACCESSION NUMBER: 0001948657-25-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20251031 DATE AS OF CHANGE: 20251030 EFFECTIVENESS DATE: 20251031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Epsilon Healthcare Innovation Fund II, LP CENTRAL INDEX KEY: 0001948657 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-465330 FILM NUMBER: 251437418 BUSINESS ADDRESS: STREET 1: 1227 25TH STREET NW STE 700 CITY: WASHINGTON STATE: DC ZIP: 20037 BUSINESS PHONE: 2026027213 MAIL ADDRESS: STREET 1: 1227 25TH STREET NW STE 700 CITY: WASHINGTON STATE: DC ZIP: 20037 D/A 1 primary_doc.xml X0708 D/A LIVE 0001948657 Epsilon Healthcare Innovation Fund II, LP 1227 25TH STREET NW SUITE 700 WASHINGTON DC DISTRICT OF COLUMBIA 20037 2026027213 DELAWARE None None Limited Partnership true 2022 Gregory H. Epstein Epsilon Healthcare Innovation Fund II,LP 1227 25TH STREET NW STE 700 Washington DC DISTRICT OF COLUMBIA 20037 Director Executive Officer Manager of Epsilon Healthcare Innovation Fund II GP, LLC, the "General Partner" of the Issuer Stevens Andrew Brady Epsilon Healthcare Innovation Fund II,LP 1227 25th Street NW, Suite 700 Washington DC DISTRICT OF COLUMBIA 20037 Executive Officer Officer of the General Partner of the Issuer Steven B. Epstein Epsilon Healthcare Innovation Fund II,LP 1227 25th Street NW, Suite 700 Washington DC DISTRICT OF COLUMBIA 20037 Director Executive Officer Manager of the General Partner of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 3C.7 06b 3C true 0000911420-24-000234 2022-12-01 true true true true General Partner discretion to accept different minimum investment amount. false 100000 50000000 17550000 32450000 false 27 0 0 1000000 true Estimated management fees payable during 1st year of the investment period of the Issuer based on aggregate commitments of $50,000,000. Add'l fees are payable for remainder of term of Issuer described in the confidential offering materials of the Issuer. false Epsilon Healthcare Innovation Fund II, LP /s/ Stevens Andrew Brady Stevens Andrew Brady Officer of the General Partner of the Issuer 2025-10-30